Legal Representation
Attorney
Pina Campagna
USPTO Deadlines
Next Deadline
907 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220712)
Due Date
July 12, 2028
Grace Period Ends
January 12, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 12, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 12, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 26, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 26, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 6, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 23, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 23, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 23, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 23, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 23, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 22, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 20, 2021 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Sep 17, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 12, 2021 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Sep 12, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 3, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for ophthalmic use; medicinal preparations and substances for ophthalmic use; liquid and semisolid pharmaceutical compositions for the treatment of eye diseases; eye drops; pharmaceutical preparations for the treatment of the dry eye disease; pharmaceutical preparations for dermatological use; medicinal preparations and substances for dermatological use; liquid and semisolid pharmaceutical compositions for the treatment of skin diseases
Classification
International Classes
005